Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 2 » default
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
- View all (571)
- Volume 16, 2023 (47)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 2, 2009
The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
Hector Clarke, Shaker A Mousa
Pharmacogenomics and Personalized Medicine 2009, 2:93-99
Published Date: 10 September 2009
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
Peter Avery, Shaymaa S Mousa, Shaker A Mousa
Pharmacogenomics and Personalized Medicine 2009, 2:79-91
Published Date: 13 September 2009
Pharmacogenomics in osteoporosis: Steps toward personalized medicine
Robert Greene, Shaymaa S Mousa, Mohamed Ardawi, et al
Pharmacogenomics and Personalized Medicine 2009, 2:69-78
Published Date: 10 September 2009
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
Christopher Barone, Shaymaa S Mousa, Shaker A Mousa
Pharmacogenomics and Personalized Medicine 2009, 2:59-67
Published Date: 8 September 2009
Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island
Thouraya Baroudi Ouederni, Ahmed Fadiel, Nejla Stambouli, et al
Pharmacogenomics and Personalized Medicine 2009, 2:49-57
Published Date: 21 August 2009
Genomics and proteomics: Applications in autoimmune diseases
Wolfgang Hueber, William H Robinson
Pharmacogenomics and Personalized Medicine 2009, 2:39-48
Published Date: 17 August 2009
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed
Steven F Powell, Arkadiusz Z Dudek
Pharmacogenomics and Personalized Medicine 2009, 2:21-37
Published Date: 24 June 2009
Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis
Janet K Coller, Julia Beardsley, James Bignold, Yibai Li, Florence Merg, et al
Pharmacogenomics and Personalized Medicine 2009, 2:9-19
Published Date: 20 March 2009
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
Avery Schwartz, Shany Blum, Rabea Asleh, Mordechai Pollak, Shiri Kalet-Litman, Andrew P Levy
Pharmacogenomics and Personalized Medicine 2009, 2:1-8
Published Date: 27 February 2009